ADHD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between the ages of 21 and 65 (men and women).
- People who have been diagnosed with ADHD according to the DSM-5 diagnostic guidelines.
- People currently taking ADHD medication who are willing to switch to a short-acting form of Ritalin (10mg, with the possibility of increasing to 20mg per dose) for the duration of the study — taken at least 8 hours before treatment sessions or at least 1 hour after, including on follow-up days. This is to ensure that any changes observed are due to the study treatment, not the medication.
- People who are willing to provide both written and verbal consent to take part in the study.
Who may not be able to join:
- People who have another active psychiatric diagnosis listed under Axis I of the DSM-5.
- People currently taking antipsychotic medications, antidepressants, or mood stabilisers.
- People who have previously had a bad reaction or intolerance to TMS (a type of brain stimulation).
- People who have been diagnosed with a severe personality disorder according to DSM-5 criteria.
- People who are currently experiencing suicidal thoughts or urges.
- People with high blood pressure that is not well controlled.
- People with a personal history of epilepsy, seizures, or febrile (fever-related) seizures.
- People who have a close biological relative (parent, sibling, or child) with a history of epilepsy or seizures.
- People who have had a head injury or major stroke that caused lasting impairment.
- People who have metal in their head (not including dental work inside the mouth).
- People with a history of surgery involving metal implants, metal particles in the eye, a pacemaker, an implanted hearing device, a neurostimulator, or any medical pump implanted in the body.
- People with a history of drug or alcohol addiction.
- People who are unable to communicate adequately with the study examiner.
- People who are currently participating in another medical study, or who have done so within the past 3 months.
- People who are unable to sign a consent form.
- People who are pregnant, or who are unwilling to commit to avoiding pregnancy or to using contraception during the study period.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Abraham Zangen, Ben-Gurion University of the Negev
Phone: +972 8-647-2646
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in ADHD Symptoms Assessed by the Conners' Adult ADHD Rating Scale (CAARS); Change in Cognitive Control Assessed by Stroop Task Performance; Change in Working Memory Assessed by N-back Task Performance; Change in EEG Power Spectral Density Across Frequency Bands; Change in Raw EEG Voltage
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.